Cargando…

Trough Concentrations of Specific Antibodies in Primary Immunodeficiency Patients Receiving Intravenous Immunoglobulin Replacement Therapy

Immunoglobulin replacement therapy is a mainstay therapy for patients with primary immunodeficiency (PID). The content of these preparations was studied extensively. Nevertheless, data regarding the effective specific antibodies content (especially in the nadir period), and, in different groups of P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassin, Ori, Abu Freih, Yahya, Hazan, Ran, Lev, Atar, Zrihen, Keren S., Somech, Raz, Broides, Arnon, Nahum, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915625/ https://www.ncbi.nlm.nih.gov/pubmed/33557365 http://dx.doi.org/10.3390/jcm10040592

Ejemplares similares

First Year of Israeli Newborn Screening for Severe Combined Immunodeficiency—Clinical Achievements and Insights
por: Rechavi, Erez, et al.
Publicado: (2017)

Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation
por: Lev, Atar, et al.
Publicado: (2019)

Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel
por: Marcus, Nufar, et al.
Publicado: (2021)

A horse or a zebra? Unusual manifestations of common cutaneous infections in primary immunodeficiency pediatric patients
por: Ollech, Ayelet, et al.
Publicado: (2023)

Novel NHEJ1 pathogenic variant linked to severe combined immunodeficiency, microcephaly, and abnormal T and B cell receptor repertoires
por: Frizinsky, Shirly, et al.
Publicado: (2022)

Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects
por: Lev, Atar, et al.
Publicado: (2020)

Inadequate Activation of γδT- and B-cells in Patient with Wiskott-Aldrich Syndrome (WAS) Portrayed by TRG and IGH Repertoire Analyses
por: Palevski, Dahlia, et al.
Publicado: (2022)

A Call to Include Severe Combined Immunodeficiency in Newborn Screening Program
por: Somech, Raz, et al.
Publicado: (2014)

Plasma Peak and Trough Gentamicin Concentrations in Hospitalized Horses Receiving Intravenously Administered Gentamicin
por: Bauquier, J.R., et al.
Publicado: (2015)

Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy
por: Wasserman, Richard L., et al.
Publicado: (2017)

Organophosphate acetylcholine esterase inhibitor poisoning from a home-made shampoo
por: Sadaka, Yair, et al.
Publicado: (2011)

GATA2 Deficiency in Adult Life Is Characterized by Phenotypic Diversity and Delayed Diagnosis
por: Shamriz, Oded, et al.
Publicado: (2022)

SARS-CoV-2 spike antibody concentration in gamma globulin products from high-prevalence COVID-19 countries are transmitted to X-linked agammaglobulinemia patients
por: Raphael, Allon, et al.
Publicado: (2023)

Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs
por: Iancu, Ortal, et al.
Publicado: (2022)

Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
por: Kaarthigeyan, K., et al.
Publicado: (2011)

Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
por: Bhatt, Girish Chandra, et al.
Publicado: (2012)

Does Intravenous Immunoglobulin Therapy Prolong Immunodeficiency in Transient Hypogammaglobulinemia of Infancy?
por: Memmedova, Lale, et al.
Publicado: (2013)

Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
por: Gill, Parwinder K., et al.
Publicado: (2018)

The Kinetics of Early T and B Cell Immune Recovery after Bone Marrow Transplantation in RAG-2-Deficient SCID Patients
por: Lev, Atar, et al.
Publicado: (2012)

Hypoparathyroidism-Retardation-Dysmorphism Syndrome due to a Variant in the Tubulin-Specific Chaperone E Gene as a Cause of Combined Immune Deficiency
por: David, Odeya, et al.
Publicado: (2022)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Steady-State Serum IgG Trough Levels Are Adequate for Pharmacokinetic Assessment in Patients with Immunodeficiencies Receiving Subcutaneous Immune Globulin
por: Li, Zhaoyang, et al.
Publicado: (2021)

Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients
por: Schroeder, H. W., et al.
Publicado: (2012)

Pneumococcal Antibody Titers: A Comparison of Patients Receiving Intravenous Immunoglobulin Versus Subcutaneous Immunoglobulin
por: Abghari, Pamella F., et al.
Publicado: (2017)

Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia
por: Varda-Bloom, Nira, et al.
Publicado: (2016)

Characterizing T Cells in SCID Patients Presenting with Reactive or Residual T Lymphocytes
por: Lev, Atar, et al.
Publicado: (2012)

Intravenous Immunoglobulin Monotherapy for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency
por: Hasegawa, Mizue, et al.
Publicado: (2017)

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
por: Perez, Elena E., et al.
Publicado: (2021)

G23D: Online tool for mapping and visualization of genomic variants on 3D protein structures
por: Solomon, Oz, et al.
Publicado: (2016)

The Effect of Gentamicin-Induced Readthrough on a Novel Premature Termination Codon of CD18 Leukocyte Adhesion Deficiency Patients
por: Simon, Amos J., et al.
Publicado: (2010)

Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience
por: Shamriz, Oded, et al.
Publicado: (2022)

Safety, efficiency, and treatment satisfaction in children with primary immunodeficiency receiving subcutaneous immunoglobulin treatment
por: Eltan, Sevgi Bilgic, et al.
Publicado: (2022)

Hospital versus home treatment of respiratory exacerbations in cystic fibrosis
por: Lavie, Moran, et al.
Publicado: (2011)

Of waves and troughs
por: Noll-Hussong, Michael
Publicado: (2014)

Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada
por: Gerth, William C, et al.
Publicado: (2014)

Fetuin-A deficiency is associated with infantile cortical hyperostosis (Caffey disease)
por: Merdler-Rabinowicz, Rona, et al.
Publicado: (2019)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Proteomic Analysis of Sera from Common Variable Immunodeficiency Patients Undergoing Replacement Intravenous Immunoglobulin Therapy
por: Spadaro, Giuseppe, et al.
Publicado: (2011)

Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
por: Wasserman, Richard L., et al.
Publicado: (2012)

Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin
por: Aljaberi, Rana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v4n8kq5n7ah5opge8h3s5oj6qo